You are here

Xenon

Xenon Looks to Raise Cash for MDD Program with $300M Public Offering

BioSpace

Thu, 11/30/23 - 11:15 pm

major depressive disorder

Xenon’s Add-On Epilepsy Treatment Shows Promising Phase IIb Efficacy, Safety

BioSpace

Tue, 10/10/23 - 11:33 am

clinical trials

Canada's Xenon touts out-of-the-blue win for its daily epilepsy pill, sending investors into a frenzy

Endpoints

Mon, 10/4/21 - 11:05 am

clinical trials

Neurocrine is beefing up its pipeline, splurging $50M on rights to an epilepsy drug

Endpoints

Mon, 12/2/19 - 10:35 am

Xenon’s epilepsy drug clears phase 1b, setting stage for trial in patients

Fierce Biotech

Wed, 08/29/18 - 10:36 am

clinical trials

Teva partner flunks second program this year

BioPharma Dive

Wed, 06/28/17 - 10:44 pm

Teva Pharmaceutical

post-herpetic neuralgia

Teva and Xenon rack up another setback as PhIIb study fails on every endpoint

Endpoints

Tue, 06/27/17 - 09:54 am

Teva Pharmaceutical

post-herpetic-neuralgia

Xenon Dumps Acne Drug After Study Failure

Investopedia

Fri, 03/24/17 - 09:42 am

clinical trials

Teva-Xenon Arthritis Pain Drug Fails Midstage Trial

Investors.com

Wed, 07/1/15 - 04:01 pm

Teva Pharmaceutical

IPO Filing: Xenon Pharmaceuticals

Yahoo/24-7 Wall St

Wed, 09/10/14 - 11:20 am

Xenon licenses antisense drug SEN701 from Isis Pharmaceuticals

Yahoo/Fly on the Wall

Mon, 06/10/13 - 10:16 am

Isis Pharmaceuticals

Teva and Xenon Announce FDA Orphan Drug Designation for Pain Drug XEN402

Yahoo

Tue, 04/23/13 - 10:50 am

erythromelalgia

Merck & Co. Picks Up Exclusive Option on Xenon CV Drugs

Genetic Engineering News

Thu, 04/18/13 - 08:22 am

Teva agrees licensing deal for Xenon pain drug

Zenopa

Thu, 12/13/12 - 04:27 pm